Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndromeTakashi Taga, Souichi Adachi, Hideki Nakayama et al.|Blood|2012Cited by 62
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Souichi Adachi, Tomoyuki Watanabe et al.|Pediatric Blood & Cancer|2015Cited by 48
High event‐free survival rate with minimum‐dose‐anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study GroupHiroyuki Takahashi, Souichi Adachi, Tomoyuki Watanabe et al.|British Journal of Haematology|2016Cited by 21
Risk-Oriented Therapy for Myeloid Leukemia of Down Syndrome: A Nationwide Prospective Study By the Japanese Pediatric Leukemia / Lymphoma Study Group (JPLSG)Takashi Taga, Souichi Adachi, Tomoyuki Watanabe et al.|Blood|2014Cited by 1